Financing BioTech Innovation: Challenges and Opportunities

HBA invites you for a fireside chat, panel discussions, and a reception to network with industry leaders and explore potential career opportunities in the healthcare industry! Please also sign up on the Event Registration link for the Wed Mar 25th event.

Keynote: Michael McDonnell (B’86, P’18, '21), former chief financial officer, Biogen
Chip Baird (SFS'93), CEO, Poplar Therapeutics
Ali Behbahani, partner and co-head of healthcare, NEA
Mitchell Chan, chief financial officer, REGENXBIO Inc.
Peter N. Crnkovich (B’78, P’11, ’13), senior advisor, Riboscience LLC
Gregg Gilbert, founder, GG Advisory Group
Evan Seigerman, managing director, head of healthcare research, and senior biotechnology and pharmaceutical analyst, BMO Capital Markets
Graig Suvannavejh (C'92, MS'93), managing director, Mizuho Americas
Joe Todisco (C'98), CEO, CorMedix

2:00 p.m. Welcome Remarks
2:15 p.m. Keynote Address: Managing Shareholder and Patient Priorities for Biotech Firms
3:00 p.m. Panel: Investor Insights: Valuation, Policy, and Pipeline Pressure in Biotech
3:45 p.m. Break
4:00 p.m. Panel: Navigating Risk and Reward: Raising Capital in Biotech
4:45 p.m. Closing Remarks
5:00 p.m. Reception

Please also sign up on the Event Registration link.

Healthcare Business Alliance (HBA) | Website | View More Events

Contact the organizers